Form D · Other

Platelet BioGenesis, Inc.

Watertown, MA · CIK 0001679766

Offering snapshot reported Nov 4, 2021 · SEC filing

Reported sold
$35.4M
Offering amount: $35.4M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 19, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 4, 2021Initial$35,416,789No comparison7SEC filing
Aug 13, 2019Amendment$26,364,976$15,000,000vs Jun 19, 201934SEC filing
Jun 19, 2019Initial$11,364,976No comparison33SEC filing
May 31, 2017Initial$10,000,000No comparison32SEC filing
Jul 28, 2016Initial$1,133,794No comparison33SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-419730

Source: Form D, filed Nov 4, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steven Altschuler Director
Steve Altschuler Director
Peter Finn Executive
Joseph Italiano Director
Sven Karlsson Director, Executive
Mark Mc Dade Director
Richard Murray Director
Sam Rasty Director, Executive
Philip Reilly Director
Jonathan Thon Director, Executive
Chidozie Ugwumba Director

Issuer details

Industry: Other (See others in industry)

Address:
65 Grove Street, Suite 303
Watertown, MA, 02472